Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Standard

Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses. / Engelbrechtsen, Line; Mahendran, Yuvaraj; Jonsson, Anna; Gjesing, Anette Prior; Weeke, Peter E; Jørgensen, Marit E.; Færch, Kristine; Witte, Daniel R.; Holst, Jens J.; Jørgensen, Torben; Grarup, Niels; Pedersen, Oluf; Vestergaard, Henrik; Torekov, Signe; Kanters, Jørgen K; Hansen, Torben.

I: B M C Genetics, Bind 19, Nr. 1, 15, 2018, s. 1-9.

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Harvard

Engelbrechtsen, L, Mahendran, Y, Jonsson, A, Gjesing, AP, Weeke, PE, Jørgensen, ME, Færch, K, Witte, DR, Holst, JJ, Jørgensen, T, Grarup, N, Pedersen, O, Vestergaard, H, Torekov, S, Kanters, JK & Hansen, T 2018, 'Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses', B M C Genetics, bind 19, nr. 1, 15, s. 1-9. https://doi.org/10.1186/s12863-018-0602-2

APA

Engelbrechtsen, L., Mahendran, Y., Jonsson, A., Gjesing, A. P., Weeke, P. E., Jørgensen, M. E., Færch, K., Witte, D. R., Holst, J. J., Jørgensen, T., Grarup, N., Pedersen, O., Vestergaard, H., Torekov, S., Kanters, J. K., & Hansen, T. (2018). Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses. B M C Genetics, 19(1), 1-9. [15]. https://doi.org/10.1186/s12863-018-0602-2

Vancouver

Engelbrechtsen L, Mahendran Y, Jonsson A, Gjesing AP, Weeke PE, Jørgensen ME o.a. Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses. B M C Genetics. 2018;19(1):1-9. 15. https://doi.org/10.1186/s12863-018-0602-2

Author

Engelbrechtsen, Line ; Mahendran, Yuvaraj ; Jonsson, Anna ; Gjesing, Anette Prior ; Weeke, Peter E ; Jørgensen, Marit E. ; Færch, Kristine ; Witte, Daniel R. ; Holst, Jens J. ; Jørgensen, Torben ; Grarup, Niels ; Pedersen, Oluf ; Vestergaard, Henrik ; Torekov, Signe ; Kanters, Jørgen K ; Hansen, Torben. / Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses. I: B M C Genetics. 2018 ; Bind 19, Nr. 1. s. 1-9.

Bibtex

@article{23421f77277b4090b2aca2f676768c3a,
title = "Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses",
abstract = "BACKGROUND: Patients with long QT syndrome due to rare loss-of-function mutations in the human ether-{\'a}-go-go-related gene (hERG) have prolonged QT interval, risk of arrhythmias, increased secretion of insulin and incretins and impaired glucagon response to hypoglycemia. This is caused by a dysfunctional Kv11.1 voltage-gated potassium channel. Based on these findings in patients with rare variants in hERG, we hypothesized that common variants in hERG may also lead to alterations in glucose homeostasis. Subsequently, we aimed to evaluate the effect of two common gain-of-function variants in hERG (rs36210421 and rs1805123) on QT interval and plasma levels of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), insulin and glucagon during an oral glucose tolerance test (OGTT). We used two population-based cohorts for evaluation of the effect of common variants in hERG on QT-interval and circulation levels of incretins, insulin and glucagon. The Danish population-based Inter99 cohort (n = 5895) was used to assess the effect of common variants on QT-interval. The Danish ADDITION-PRO cohort was used (n = 1329) to study genetic associations with levels of GLP-1, GIP, insulin and glucagon during an OGTT.RESULTS: Carriers of either the minor A-allele of rs36210421 or the minor G-allele of rs1805123 had ~ 2 ms shorter QT interval per risk allele (p = 0.025 and p = 1.9 × 10- 7). Additionally, both variants were associated with alterations in pancreatic and gut hormone release among carriers. The minor A- allele of rs36210421 was associated with increased GLP-1 and decreased GIP response to oral glucose stimulation, whereas the minor G-allele of rs1805123 is associated with decreased fasting plasma insulin and glucagon release. A genetic risk score combining the two gene variants revealed reductions in glucose-stimulated GIP, as well as suppressed glucagon response to increased glucose levels during an OGTT.CONCLUSIONS: Two common missense polymorphisms of the Kv11.1 voltage-gated hERG potassium channel are associated with alterations in circulating levels of GIP and glucagon, suggesting that hERG potassium channels play a role in fasting and glucose-stimulated release of GIP and glucagon.TRIAL REGISTRATION: ClinicalTrials.gov ( NCT00289237 ). Trial retrospectively registered at February 9, 2006. Studies were approved by the Ethical Committee of the Central Denmark Region (journal no. 20080229) and by the Copenhagen County Ethical Committee (KA 98155).",
author = "Line Engelbrechtsen and Yuvaraj Mahendran and Anna Jonsson and Gjesing, {Anette Prior} and Weeke, {Peter E} and J{\o}rgensen, {Marit E.} and Kristine F{\ae}rch and Witte, {Daniel R.} and Holst, {Jens J.} and Torben J{\o}rgensen and Niels Grarup and Oluf Pedersen and Henrik Vestergaard and Signe Torekov and Kanters, {J{\o}rgen K} and Torben Hansen",
year = "2018",
doi = "10.1186/s12863-018-0602-2",
language = "English",
volume = "19",
pages = "1--9",
journal = "BMC Genetics",
issn = "1471-2156",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses

AU - Engelbrechtsen, Line

AU - Mahendran, Yuvaraj

AU - Jonsson, Anna

AU - Gjesing, Anette Prior

AU - Weeke, Peter E

AU - Jørgensen, Marit E.

AU - Færch, Kristine

AU - Witte, Daniel R.

AU - Holst, Jens J.

AU - Jørgensen, Torben

AU - Grarup, Niels

AU - Pedersen, Oluf

AU - Vestergaard, Henrik

AU - Torekov, Signe

AU - Kanters, Jørgen K

AU - Hansen, Torben

PY - 2018

Y1 - 2018

N2 - BACKGROUND: Patients with long QT syndrome due to rare loss-of-function mutations in the human ether-á-go-go-related gene (hERG) have prolonged QT interval, risk of arrhythmias, increased secretion of insulin and incretins and impaired glucagon response to hypoglycemia. This is caused by a dysfunctional Kv11.1 voltage-gated potassium channel. Based on these findings in patients with rare variants in hERG, we hypothesized that common variants in hERG may also lead to alterations in glucose homeostasis. Subsequently, we aimed to evaluate the effect of two common gain-of-function variants in hERG (rs36210421 and rs1805123) on QT interval and plasma levels of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), insulin and glucagon during an oral glucose tolerance test (OGTT). We used two population-based cohorts for evaluation of the effect of common variants in hERG on QT-interval and circulation levels of incretins, insulin and glucagon. The Danish population-based Inter99 cohort (n = 5895) was used to assess the effect of common variants on QT-interval. The Danish ADDITION-PRO cohort was used (n = 1329) to study genetic associations with levels of GLP-1, GIP, insulin and glucagon during an OGTT.RESULTS: Carriers of either the minor A-allele of rs36210421 or the minor G-allele of rs1805123 had ~ 2 ms shorter QT interval per risk allele (p = 0.025 and p = 1.9 × 10- 7). Additionally, both variants were associated with alterations in pancreatic and gut hormone release among carriers. The minor A- allele of rs36210421 was associated with increased GLP-1 and decreased GIP response to oral glucose stimulation, whereas the minor G-allele of rs1805123 is associated with decreased fasting plasma insulin and glucagon release. A genetic risk score combining the two gene variants revealed reductions in glucose-stimulated GIP, as well as suppressed glucagon response to increased glucose levels during an OGTT.CONCLUSIONS: Two common missense polymorphisms of the Kv11.1 voltage-gated hERG potassium channel are associated with alterations in circulating levels of GIP and glucagon, suggesting that hERG potassium channels play a role in fasting and glucose-stimulated release of GIP and glucagon.TRIAL REGISTRATION: ClinicalTrials.gov ( NCT00289237 ). Trial retrospectively registered at February 9, 2006. Studies were approved by the Ethical Committee of the Central Denmark Region (journal no. 20080229) and by the Copenhagen County Ethical Committee (KA 98155).

AB - BACKGROUND: Patients with long QT syndrome due to rare loss-of-function mutations in the human ether-á-go-go-related gene (hERG) have prolonged QT interval, risk of arrhythmias, increased secretion of insulin and incretins and impaired glucagon response to hypoglycemia. This is caused by a dysfunctional Kv11.1 voltage-gated potassium channel. Based on these findings in patients with rare variants in hERG, we hypothesized that common variants in hERG may also lead to alterations in glucose homeostasis. Subsequently, we aimed to evaluate the effect of two common gain-of-function variants in hERG (rs36210421 and rs1805123) on QT interval and plasma levels of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), insulin and glucagon during an oral glucose tolerance test (OGTT). We used two population-based cohorts for evaluation of the effect of common variants in hERG on QT-interval and circulation levels of incretins, insulin and glucagon. The Danish population-based Inter99 cohort (n = 5895) was used to assess the effect of common variants on QT-interval. The Danish ADDITION-PRO cohort was used (n = 1329) to study genetic associations with levels of GLP-1, GIP, insulin and glucagon during an OGTT.RESULTS: Carriers of either the minor A-allele of rs36210421 or the minor G-allele of rs1805123 had ~ 2 ms shorter QT interval per risk allele (p = 0.025 and p = 1.9 × 10- 7). Additionally, both variants were associated with alterations in pancreatic and gut hormone release among carriers. The minor A- allele of rs36210421 was associated with increased GLP-1 and decreased GIP response to oral glucose stimulation, whereas the minor G-allele of rs1805123 is associated with decreased fasting plasma insulin and glucagon release. A genetic risk score combining the two gene variants revealed reductions in glucose-stimulated GIP, as well as suppressed glucagon response to increased glucose levels during an OGTT.CONCLUSIONS: Two common missense polymorphisms of the Kv11.1 voltage-gated hERG potassium channel are associated with alterations in circulating levels of GIP and glucagon, suggesting that hERG potassium channels play a role in fasting and glucose-stimulated release of GIP and glucagon.TRIAL REGISTRATION: ClinicalTrials.gov ( NCT00289237 ). Trial retrospectively registered at February 9, 2006. Studies were approved by the Ethical Committee of the Central Denmark Region (journal no. 20080229) and by the Copenhagen County Ethical Committee (KA 98155).

U2 - 10.1186/s12863-018-0602-2

DO - 10.1186/s12863-018-0602-2

M3 - Journal article

C2 - 29548277

VL - 19

SP - 1

EP - 9

JO - BMC Genetics

JF - BMC Genetics

SN - 1471-2156

IS - 1

M1 - 15

ER -

ID: 195509010